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Since November 2006, Switzerland has been experiencing 
the largest measles outbreak registered in the country since the 
introduction of mandatory notification for this disease in 1999. 
The first eight months of this outbreak have already been described 
in this journal [1]. From November 2006 to 13 February 2008, 
1,405 measles cases were reported by physicians or laboratories 
in Switzerland (1,106 of them in 2007). Of these, 976 cases 
(69%) occurred in the cantons of Lucerne (29% of the total), 
Basel-Land (16%), Zurich (11%) Bern (7%), and Aargau (7%). The 
incidence for the whole country and all ages, calculated for this 
15-month period, was 19 cases per 100,000 inhabitants (15 cases 
per 100,000 for the year 2007). For children under the age of 16 
years living in the canton of Lucerne, it was 500 per 100,000. 
Outbreak description
The ongoing outbreak began among school-age children in the 
canton of Lucerne. Its origin remains unknown. The disease then 
spread progressively to all Swiss cantons, with large differences 
in incidence rates and a great variety of settings (Figures 1 and 
2). Measles virus (MV) of genotype D5 was detected in saliva or 
throat swabs from 56 patients living in 10 cantons. Most of the 
MV sequences obtained from these cases were identical, and some 
showed only one or two nucleotide differences from the major 
variant. The first sample was taken in November 2006 in the canton 
of Lucerne, while the last was collected in November 2007 in 
the canton of Basel-Land. In addition, one genotype A-related 
vaccine virus was found in a woman vaccinated post-partum with 
the measles/mumps/rubella (MMR) vaccine and presenting 13 days 
after vaccination with a typical measles rash. B3 virus was isolated 
from two cases who had recently been abroad. One had returned 
from Italy four days prior to rash onset, the other from Ethiopia two 
days prior to onset of symptoms. 
 The monthly number of cases has increased steadily from 
November 2006 to a first peak in August 2007 with 170 reported 
cases (Figure 3). The number of cases then decreased to a minimum 
of 60 in December before reaching a second peak in January with 
233 cases. Since October 2007, most cases were registered in 
the cantons of Basel-City and especially Basel-Land in northern 
Switzerland (64% of total cases since the beginning of 2008). 
About half of the cases (693 or 49%) have been confirmed, either 
by detecting measles-IgM antibody or the measles virus RNA by RT-
PCR (555 or 40%), or by an epidemiological link with a laboratory-
confirmed case (138 or 10%). Due to the increasing proportion 
of cases who have not provided a sample for laboratory testing 
or information about an epidemiological link, these proportions 
have decreased since the first half of the outbreak, whereas the 
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Cumulative measles incidence rate and number of cases 
reported through the national mandatory notification 
system, by canton, Switzerland, November 2006 to 13 
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F i g u r e  2
Cantonal vaccination coverage of two-year-old children with 
a first dose of measles/mumps/rubella or measles vaccine, 
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proportion of cases fulfilling only the clinical case definition (fever 
and rash, as well as cough or rhinitis or conjunctivitis) has increased 
to 43%. The proportion of cases for whom clinical data are not yet 
available or who did not completely fulfil the case definition has 
remained unchanged (8%). 
There has been a slight majority (51%) of males among the 
cases (Table). The patients’ median age has been 11 years. The 
median age has increased recently: in late 2006 and 2007, 29% 
of the patients were 15 years old or older, compared to 53% since 
the beginning of 2008. The incidence rate was highest in the 
five- to nine-year-old group. Six percent of the 1,319 cases with 
detailed information were vaccinated against measles, 85% were 
unvaccinated, and the vaccination status of the remaining 8% 
was unknown. 
The proportion of vaccinated patients has been low for all 
ages (Figure 4). There were 104 cases (8% of 1,319 cases for 
whom information about hospitalisation and complications were 
available) who required hospitalisation. Six cases were reported 
with encephalitis or suspicion of encephalitis (0.5%), all among 
children. No deaths have been reported. 
Control measures
In Switzerland, the cantons are responsible for outbreak control 
measures. Various measures were implemented by the cantonal 
medical authorities in response to this ongoing outbreak, including 
targeted and general information for the public, contact tracing, 
recommendation to complete immunisation if necessary (two MMR 
doses for people without proof of immunity born after 1963), and 
exclusion from school for non-immune siblings of cases [1]. To 
our knowledge, no supplementary immunisation activity has been 
organised specifically in response to the outbreak, and it is not 
known to what extent the recommendation to carry out catch-up 
vaccinations has been followed. The nature and intensity of the 
measures taken has also varied between cantons. 
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Epidemiologic curve of the measles outbreak in Switzerland, 
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F i g u r e  4 
Vaccination status by age of measles cases reported in 
Switzerland between November 2006 and the 13th February 






































T a b l e 
Descriptive epidemiology of measles cases reported in 
Switzerland between November 2006 and the 13 February 
2008 (n=1,405)
Epidemiological 
characteristics Category No. of cases %  IR*
Total cases  1,405 100.0 19.0
Sex
Male 714 50.9 19.4
Female 688 49.1 18.0
Unknown 3  
Age groups 
( years)
< 1 35 2.5 47.9
1 - 4 175 12.5 59.7
5 - 9 374 26.8 96.3
10 - 14 339 24.3 79.2
15 - 19 240 17.2 53.7
20 - 29 107 7.7 11.7
30 - 39 85 6.1 7.7
≥ 40 42 3.0 1.1
Unknown 8  
Vaccination 
status**
Vaccinated 84 6.4  
   1 dose 60 4.5  
   ≥ 2 doses 20 1.5  
   unknown no. of
   doses 4 0.3  
Unvaccinated 1,124 85.2  
Unknown 111 8.4  
Hospitalisations**  104 7.9  
Pneumonia**  63 4.8  
Otitis media**  62 4.7  
Encephalitis**  6 0.5  
*   Incidence rate per 100,000 inhabitants 
** Calculated for 1,319 cases with detailed information
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Discussion
This ongoing nationwide outbreak of measles in Switzerland 
is characterised by its long duration (15 months to date), a peak 
in the summer, its spatial heterogeneity in incidence, and a high 
incidence compared to other European countries. The outbreak 
has mainly affected unvaccinated children of school age, but also 
unvaccinated young adults. Transmission occurred primarily in 
families and schools. 
The unusual length of this outbreak is probably the result 
of the proportion and distribution of susceptible persons in the 
population, allowing the infection to spread gradually without 
necessarily leading to a rapid exhaustion of the pool of susceptible 
individuals. The national measles vaccination coverage of 86% 
for the first dose at the age of two and of 70% for the second 
dose (introduced in 1996) seems to be high enough to prevent an 
explosive and large outbreak of shorter duration. However, it is not 
sufficiently high for an interruption of sustained MV transmission 
with only minimal control measures. Moreover, vaccination coverage 
stagnated at around 82% between 1991 and the beginning of 
this decade, allowing for the accumulation of a large number of 
susceptible individuals. 
As suggested in Figure 3, a detailed analysis of the temporal and 
geographical distribution of cases shows that this large national 
outbreak is broken down into successive local and regional clusters 
with partial overlap. Due to insufficient vaccination coverage 
combined with a high heterogeneity between the cantons (from 
69% to 94%) and due to the time elapsed since the last large 
outbreak in 2003 that had about 700 reported cases, measles 
virus can progressively spread to new regions, in particular among 
communities of people preferring alternative medicine and education 
methods (homoeopathy and anthroposophy). The circulation of the 
same genetic variant of MV since November 2006 indicates a 
single nationwide outbreak. This imported D5 MV has its origin 
in South-East Asia and has been continuously transmitted within 
Switzerland over a period of at least 15 months. It can therefore 
be considered as “newly endemic” at present. 
Such a long outbreak or successive outbreaks of short duration are 
not unusual in settings where unvaccinated individuals accumulate 
over time due to poor uptake of vaccine. In 1999–2000, the 
Netherlands experienced an almost year-long measles outbreak 
with about 3,300 cases, which started among unvaccinated 
individuals in areas with low vaccination coverage; however, there 
was only sporadic spread to communities with high vaccination 
coverage] [2]. A very large outbreak raged in Italy in 2002 and 
again in 2003, after a few quiet months [3]. Bolker and Grenfell 
have hypothesised that an intermediate vaccination coverage could 
decorrelate the timing of regional outbreaks in the same country [4], 
with a consecutive extension of the total duration of the outbreak. 
Measles elimination (interruption of endemic disease transmission) 
has been achieved in countries that have a sustained high coverage 
with two doses of measles vaccine [5,6]. 
In areas where it remains endemic, measles is considered a 
seasonal disease with epidemic peak usually in late winter or early 
spring. Its temporal pattern seems to be influenced by school 
holidays, even after the introduction of measles vaccination [7]. 
The dry indoor humidity could also explain the peak during the cold 
season in the northern hemisphere [8]. Surprisingly, the current 
outbreak began in mid-autumn, a period that usually has a very low 
incidence in Switzerland, and peaked during July to September, 
although the number of cases usually sharply decreases after 
the spring peak. Despite the summer closure of schools, 56% of 
patients were of school-age during that period. 
Figure 1 shows that most cases were concentrated in north, 
east and central Switzerland, with a relatively low incidence in 
the western and southern part of the country, corresponding to the 
French- and Italian-speaking region. The incidence was only three 
per 100,000 in this region compared to 26 per 100,000 in the 
German-speaking region, with vaccination coverage of about 92% 
and 85%, respectively. However, the correlation between measles 
vaccination coverage and the incidence rate remained moderate 
at a cantonal level. 
Switzerland has endorsed the goal to eliminate indigenous 
measles and rubella in the European Region of the World Health 
Organization (WHO EURO) by 2010 [9,10]. Nevertheless, 
Switzerland experienced the highest measles incidence rate of 
central and western Europe for 2007, with 15 cases per 100,000 
inhabitants. According to EUVACNET reports [http://www.euvac.
net], during the first three quarters of 2007 Switzerland notified 
29% of all measles cases from the 32 European countries that 
report to EUVAC.net, and as many as 42% for the third quarter 
alone. It thus constitutes a potential source of imported measles 
for other countries in Europe and elsewhere. Importations have 
already been reported in Germany, causing an outbreak in Lower 
Bavaria [11], in Denmark (one sporadic case), in England (two 
sporadic cases), and in the United States (three imported cases in 
2007 and one in 2008 that has led to an outbreak in a community 
with a high (circa 10%) level of exemption from school vaccination 
requirements due to personal beliefs [12]. The Swiss federal 
office of public health urges unvaccinated Swiss people born after 
1963 to receive two doses of an MMR vaccine and invites foreign 
visitors to be vaccinated before travelling in Switzerland. This 
recommendation is particularly important for people intending 
to visit large events such as the European football championship 
(EURO 2008) in June.
*Erratum
In Figure 2 of this article, the area representing the canton of Basel-City was 
mistakenly left in white instead of dark blue. This was corrected on 26 February 
2008.   
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